The FDA approval of the Wegovy pill highlights many of the key themes Novo Nordisk will have to face in 2026.
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market
Related Posts
Businesses are finding a workaround for tariffs — and it’s entirely legal
The “first sale rule” is a concept in U.S. customs law that allows importers to use the lowest cost of…
Meta AI Introduces Brain2Qwerty: A New Deep Learning Model for Decoding Sentences from Brain Activity with EEG or MEG while Participants Typed Briefly Memorized Sentences on a QWERTY Keyboard
Brain-computer interfaces (BCIs) have seen significant progress in recent years, offering communication solutions for individuals with speech or motor impairments.…
Tech companies want nuclear power. Some utilities are throwing up roadblocks
Investors are looking at nuclear plants as an increasingly valuable resource as data centers’ power needs grow.